Retrospective analysis of ribociclib and letrozole as first-line therapy in patients with hormone receptor (HR) positive metastatic breast cancer (MBC) within a managed access program (MAP) in Turkey
ASCO 2020, Illinois, United States Of America, 29 May 2020 - 31 May 2021, pp.130, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Doi Number: 10.1200/jco.2020.38.15_suppl.e13055
- City: Illinois
- Country: United States Of America
- Page Numbers: pp.130
- Akdeniz University Affiliated: Yes